Tempus
Tempus raises $200M Series F at $8.1B valuation
Quick Facts
Tempus: Series F Funding Round
Tempus has successfully raised $200M in Series F funding, reaching a valuation of $8.1B.
Company Overview
AI-powered precision medicine platform
Funding Details
The Series F round was led by Baillie Gifford, with participation from Franklin Templeton.
Company Information
- Headquarters: Chicago, IL
- Founded: 2015
- Employees: 1000+
- Category: HealthTech
Investment
Tempus plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Baillie Gifford: Verified investor in Series F
- Franklin Templeton: Verified investor in Series F
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
